cas 1170861-12-7|| where to buy 2-[5-(2H-1,3-benzodioxol-5-yl)-1,2-oxazol-3-yl]-1-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-one

Nombre del producto:2-[5-(2H-1,3-benzodioxol-5-yl)-1,2-oxazol-3-yl]-1-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-one

IUPAC Name:2-[5-(2H-1,3-benzodioxol-5-yl)-1,2-oxazol-3-yl]-1-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-one

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1170861-12-7 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1170861-12-7; Fórmula molecular:C21H18N2O4; Punto de fusión:-; Código de sonrisas:O=C(CC1=NOC(=C1)C1=CC2=C(OCO2)C=C1)N1CCC2=C(C1)C=CC=C2; Densidad:

: Número de catálogo:CM835389; Peso molecular:362.39; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Isoxazoles; Isoxazole is a liquid heterocyclic compound C3H3NO isomeric with oxazole and having a penetrating odor like that of pyridine. Isoxazoles belong to an important class of five-membered aromatic heterocycles containing two electronegative heteroatoms, nitrogen and oxygen, in a 1,2-relationship and three regular sp2 carbon atoms. These molecules are found to be key components in various synthetic products in daily use and also present as a pharmacophore essential for biological activity in many drugs and bioactive natural products. In addition, isoxazoles have demonstrated their ability to exhibit hydrogen bond donor/acceptor interactions with a variety of enzymes and receptors.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.